Green Planet Bio Reiterates Going Concern Warning with $517,825 Working Capital Deficit
GPLB filed a Earnings and Guidance on elevated volume (2.8× avg).
Summary
Green Planet Bio Engineering's Q2 2026 report confirms it is still a shell company with no operations, zero cash, and a going concern warning. It depends on related party advances to stay afloat.
Key Events · Earnings and Guidance · GPLB
-
Going Concern Warning Reiterated
The company has a working capital deficit of $517,825 and an accumulated deficit of $1,147,445 as of June 30, 2026, with no current business activity.
-
Zero Cash and No Revenue
Cash balance is $0, and the company reported a net loss of $16,849 for the six months ended June 30, 2026, up from $10,945 in the prior year period.
-
Related Party Funding Dependency
Amount due to a related party increased to $513,975, interest-free, unsecured, and repayable upon demand. The related party advanced an additional $3,850 after quarter end.
-
No Equity Issuances
The company did not issue any shares of common stock or warrants during the six months ended June 30, 2026.
Analysis · GPLB · Life Sciences
The company remains a non-operating shell with zero cash and a growing working capital deficit. It relies entirely on interest-free, unsecured advances from a related party of the majority stockholder to fund operations. The going concern warning is reiterated, and the accumulated deficit has widened to $1,147,445. The related party advanced an additional $3,850 after quarter end, underscoring the company's complete dependence on this funding source.
At the time of this filing, GPLB was trading at $0.01 on OTC in the Life Sciences sector, with a market capitalization of approximately $176.1K. The 52-week trading range was $0.00 to $2.60. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.